NIUM
NIUM | Personalized metabolic health.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Seed | |
| Total Funding | 000k | ||
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 50 % | 33 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | 44 % | (32 %) | 4 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 32 % | (43 %) | (4 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Nium.io is a pioneering startup specializing in personalized nutrition solutions. Originating as a spin-off from the Luxembourg Centre for Systems Biomedicine at the University of Luxembourg, Nium leverages cutting-edge research and advanced bioinformatics to offer tailored nutritional advice based on an individual's unique metabolism. The company operates in the health and wellness market, focusing on improving overall health through personalized dietary recommendations.
Nium's primary clients include healthcare providers, researchers, and individuals seeking to optimize their health through nutrition. By analyzing clinical and experimental data, Nium provides insights into the microbiome (the community of microorganisms living in our bodies), metabolism (how our bodies convert food into energy), and overall health. Their services are particularly valuable for those dealing with chronic conditions or looking to enhance their well-being through diet.
The business model of Nium revolves around a subscription-based platform where users can access personalized nutrition plans. These plans are developed using in vitro experiments (tests done in a controlled environment outside a living organism) and gut-on-a-chip models (miniaturized devices that simulate the human gut). This approach helps in building evidence on the health impacts of various ingredients and food products.
Nium makes money by offering these subscription services to individuals and licensing its technology and data to healthcare providers and researchers. The company also collaborates on studies, such as their recent announcement on personalized nutrition in cancer, which further validates their approach and expands their market reach.
In summary, Nium.io is at the forefront of personalized nutrition, combining advanced research with practical applications to improve health outcomes. Their innovative approach and strong research foundation position them as a leader in the personalized nutrition space.
Keywords: personalized nutrition, metabolism, microbiome, bioinformatics, in vitro experiments, gut-on-a-chip, health impact, chronic conditions, dietary recommendations, subscription platform.